{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:35:47Z","timestamp":1789104947876,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ftirma Kurumu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.bmcl.2021.127827","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T22:00:01Z","timestamp":1611612001000},"page":"127827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Design, synthesis, characterization, and anticancer activity of a novel series of O-substituted chalcone derivatives"],"prefix":"10.1016","volume":"35","author":[{"given":"Bath\u00e9l\u00e9my","family":"Ngameni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamdoum","family":"Cedric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armelle T.","family":"Mbaveng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musa","family":"Erdo\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Simo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Kuete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9577-2251","authenticated-orcid":false,"given":"Arif","family":"Da\u015ftan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2021.127827_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112062","article-title":"1, 2, 3-Triazole-Chalcone hybrids: Synthesis, in vitro cytotoxic activity and mechanistic investigation of apoptosis induction in multiple myeloma RPMI-8226","volume":"189","author":"Ashour","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2021.127827_b0010","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00044-018-02283-4","article-title":"Synthesis and anticancer activity of chalcone analogues with sulfonyl groups","volume":"28","author":"Mu\u0161kinja","year":"2019","journal-title":"Med Chem Res."},{"key":"10.1016\/j.bmcl.2021.127827_b0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bioorg.2019.03.014","article-title":"Synthesis and evaluation of novel \u03b1-substituted chalcones with potent anti-cancer activities and ability to overcome multidrug resistance","volume":"87","author":"Riaz","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2021.127827_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103761","article-title":"Discovery of thiazole-based-chalcones and 4-hetarylthiazoles as potent anticancer agents: Synthesis, docking study and anticancer activity","volume":"98","author":"Farghaly","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2021.127827_b0025","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1007\/s00044-018-2156-2","article-title":"Heterocycles 44. Synthesis, characterization and anticancer activity of new thiazole ortho-hydroxychalcones","volume":"27","author":"Coman","year":"2018","journal-title":"Med Chem Res"},{"key":"10.1016\/j.bmcl.2021.127827_b0030","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/00397911.2020.1720737","article-title":"Synthesis, characterization of novel quinoline-2-carboxamide based chalcone derivatives and their molecular docking, photochemical studies","volume":"50","author":"Thirumurugan","year":"2020","journal-title":"Synth Commun"},{"key":"10.1016\/j.bmcl.2021.127827_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103565","article-title":"Design, synthesis, biological evaluation and molecular docking studies of new chalcone derivatives containing diaryl ether moiety as potential anticancer agents and tubulin polymerization inhibitors","volume":"95","author":"Wang","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2021.127827_b0040","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1039\/C7NJ00265C","article-title":"Design and in vitro biological evaluation of substituted chalcones synthesized from nitrogen mustards as potent microtubule targeted anticancer agents","volume":"41","author":"Sabina","year":"2017","journal-title":"New J Chem"},{"key":"10.1016\/j.bmcl.2021.127827_b0045","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1021\/acs.chemrev.7b00020","article-title":"Chalcone: a privileged structure in medicinal chemistry","volume":"117","author":"Zhuang","year":"2017","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2021.127827_b0050","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1080\/00397911.2019.1695839","article-title":"A new series of thiazolyl pyrazoline derivatives linked to benzo [1,3] dioxole moiety: Synthesis and evaluation of antimicrobial and anti-proliferative activities","volume":"50","author":"Mansour","year":"2020","journal-title":"Synth Commun"},{"key":"10.1016\/j.bmcl.2021.127827_b0055","doi-asserted-by":"crossref","first-page":"8520","DOI":"10.1021\/acs.jpca.8b06787","article-title":"Antiradical activity and mechanism of coumarin-chalcone hybrids: Theoretical insights","volume":"122","author":"Xue","year":"2018","journal-title":"J Phys Chem A"},{"key":"10.1016\/j.bmcl.2021.127827_b0060","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1021\/acs.molpharmaceut.8b00288","article-title":"In Vitro Osteogenic Differentiation and Antibacterial Potentials of Chalcone Derivatives","volume":"15","author":"Choi","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bmcl.2021.127827_b0065","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1039\/C8MD00284C","article-title":"Novel hybrids derived from aspirin and chalcones potently suppress colorectal cancer in vitro and in vivo","volume":"9","author":"Lu","year":"2018","journal-title":"MedChemComm"},{"key":"10.1016\/j.bmcl.2021.127827_b0070","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00044-019-02492-5","article-title":"Synthesis, in vitro antigiardial activity, SAR analysis and docking study of substituted chalcones","volume":"29","author":"C\u00e1ceres-Castillo","year":"2020","journal-title":"Med Chem Res"},{"key":"10.1016\/j.bmcl.2021.127827_b0075","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bioorg.2019.02.016","article-title":"Synthesis of novel chalcones through palladium-catalyzed CO cross-coupling reaction of bromo-chalcones with ethyl acetohydroxamate and their antiplasmodial evaluation against Plasmodium falcipuram in vitro","volume":"86","author":"Vinoth","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2021.127827_b0080","doi-asserted-by":"crossref","first-page":"24204","DOI":"10.1039\/C7RA01705G","article-title":"Effect of solvent polarity on the photophysical properties of chalcone derivatives","volume":"7","author":"Kumari","year":"2017","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmcl.2021.127827_b0085","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.bmc.2011.11.068","article-title":"Antioxidant properties of 4-quinolones and structurally related flavones","volume":"20","author":"Greeff","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2021.127827_b0090","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.micpath.2019.04.015","article-title":"Antimicrobial activity of novel chalcones and modulation of virulence factors in hospital strains of Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"131","author":"U\u0161jak","year":"2019","journal-title":"Microb Pathog"},{"key":"10.1016\/j.bmcl.2021.127827_b0095","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1007\/s00044-019-02435-0","article-title":"Antimalarial, antiproliferative, and apoptotic activity of quinoline-chalcone and quinoline-pyrazoline hybrids. A dual action","volume":"28","author":"Charris","year":"2019","journal-title":"Med Chem Res"},{"key":"10.1016\/j.bmcl.2021.127827_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103133","article-title":"Chalcone derivatives and their antibacterial activities: current development","volume":"91","author":"Xu","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2021.127827_b0105","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.bmc.2011.01.047","article-title":"Synthesis, biological evaluation and 3D-QSAR studies of 3-keto salicylic acid chalcones and related amides as novel HIV-1 integrase inhibitors","volume":"19","author":"Sharma","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2021.127827_b0110","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1016\/j.bmcl.2017.10.033","article-title":"Corrigendum to \u201cA novel intestinal-restricted FXR agonist\u201d [Bioorg Med Chem Lett 27 (2017) 3386\u20133390]","volume":"27","author":"Wang","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2021.127827_b0115","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1007\/s00044-019-02423-4","article-title":"Multifunctional indanone\u2013chalcone hybrid compounds with anti-\u03b2-amyloid (A\u03b2) aggregation, monoamine oxidase B (MAO-B) inhibition and neuroprotective properties against Alzheimer\u2019s disease","volume":"28","author":"Wang","year":"2019","journal-title":"Med Chem Res"},{"key":"10.1016\/j.bmcl.2021.127827_b0120","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ejmech.2014.10.068","article-title":"Identification of quinoline-chalcone hybrids as potential antiulcer agents","volume":"89","author":"Sashidhara","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2021.127827_b0125","doi-asserted-by":"crossref","first-page":"20381","DOI":"10.1021\/acsomega.9b03077","article-title":"Design, Synthesis, and Anticancer Activity of Novel Trimethoxyphenyl-Derived Chalcone-Benzimidazolium Salts","volume":"4","author":"Yang","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmcl.2021.127827_b0130","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1021\/acs.jmedchem.8b01755","article-title":"Discovery of novel quinolone-chalcone derivatives as potent antitumor agents with microtubule polymerization inhibitory activity","volume":"62","author":"Li","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2021.127827_b0135","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.intimp.2015.01.012","article-title":"Anti-inflammatory activity of flavonoids in Nepalese propolis is attributed to inhibition of the IL-33 signaling pathway","volume":"25","author":"Funakoshi-Tago","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.bmcl.2021.127827_b0140","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0167-4838(01)00276-X","article-title":"Inhibition of epidermal growth factor receptor tyrosine kinase by chalcone derivatives","volume":"1550","author":"Yang","year":"2001","journal-title":"Biochim Biophys Acta Protein Struct Mol Enzymol"},{"key":"10.1016\/j.bmcl.2021.127827_b0145","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.foodchem.2014.09.139","article-title":"Chemical transformations of characteristic hop secondary metabolites in relation to beer properties and the brewing process: a review","volume":"172","author":"Steenackers","year":"2015","journal-title":"Food Chem"},{"key":"10.1016\/j.bmcl.2021.127827_b0150","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/jphp.12107","article-title":"Compounds isolated from P soralea corylifolia seeds inhibit protein kinase activity and induce apoptotic cell death in mammalian cells","volume":"65","author":"Limper","year":"2013","journal-title":"Pharm Pharmacol"},{"key":"10.1016\/j.bmcl.2021.127827_b0155","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1248\/bpb.30.1878","article-title":"Isobavachalcone, a chalcone constituent of Angelica keiskei, induces apoptosis in neuroblastoma","volume":"30","author":"Nishimura","year":"2007","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.bmcl.2021.127827_b0160","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1124\/mol.109.057448","article-title":"Licochalcone a potently inhibits Tumor Necrosis Factor \u03b1-Induced Nuclear Factor-\u03baB activation through the direct inhibition of I\u03baB Kinase complex activation","volume":"76","author":"Funakoshi-Tago","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bmcl.2021.127827_b0165","doi-asserted-by":"crossref","first-page":"88453","DOI":"10.1039\/C6RA16948A","article-title":"The synthesis and evaluation of new benzophenone derivatives as tubulin polymerization inhibitors","volume":"6","author":"Zhang","year":"2016","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmcl.2021.127827_b0170","first-page":"103","article-title":"A safety study of oral tangeretin and xanthohumol administration to laboratory mice","volume":"19","author":"Vanhoecke","year":"2005","journal-title":"Vivo"},{"key":"10.1016\/j.bmcl.2021.127827_b0175","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.bmcl.2009.12.062","article-title":"Synthesis, antimalarial and antitubercular activity of acetylenic chalcones","volume":"20","author":"Hans","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2021.127827_b0180","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1016\/j.bmcl.2010.10.038","article-title":"Synthesis and biological evaluation of retinoid-chalcones as inhibitors of colon cancer cell growth","volume":"20","author":"Mizuno","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2021.127827_b0185","first-page":"233","article-title":"Synthesis and evaluation of anticancer activity of O-allylchalcone derivatives","volume":"3","author":"Ngameni","year":"2013","journal-title":"Med Chem"},{"key":"10.1016\/j.bmcl.2021.127827_b0190","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.saa.2012.01.058","article-title":"Synthesis and crystal structure of hydroxyacetophenone Schiff bases containing propargyl moiety: Solvent effects on UV\u2013visible spectra","volume":"91","author":"Selvarani","year":"2012","journal-title":"Spectrochim Acta Part A"},{"key":"10.1016\/j.bmcl.2021.127827_b0195","first-page":"6","article-title":"Spectral and thermal studies of some Mn (II) and Co (II) complexes ofacetylenic amines ligands and study of its biological activity","volume":"3","author":"AL-Obaidi OHS.","year":"2012","journal-title":"J Chem"},{"key":"10.1016\/j.bmcl.2021.127827_b0200","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1007\/s00044-014-0922-3","article-title":"Synthesis, molecular docking study, and evaluation of the antiproliferative action of a new group of propargylthio-and propargylselenoquinolines","volume":"23","author":"Marciniec","year":"2014","journal-title":"Med Chem Res"},{"key":"10.1016\/j.bmcl.2021.127827_b0205","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1021\/jm000023o","article-title":"Subtype-selective N-methyl-D-aspartate receptor antagonists: synthesis and biological evaluation of 1-(heteroarylalkynyl)-4-benzylpiperidines","volume":"43","author":"Wright","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2021.127827_b0210","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1021\/cr0783479","article-title":"Cu-catalyzed azide\u2212 alkyne cycloaddition","volume":"108","author":"Meldal","year":"2008","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2021.127827_b0215","first-page":"205","article-title":"Palladium-catalyzed cross-coupling reactions in the synthesis of pharmaceuticals","volume":"vol 6","author":"King","year":"2004"},{"key":"10.1016\/j.bmcl.2021.127827_b0220","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ejmech.2019.02.028","article-title":"Novel prenyloxy chalcones as potential leishmanicidal and trypanocidal agents: Design, synthesis and evaluation","volume":"167","author":"Espinoza-Hicks","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2021.127827_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.tetlet.2019.151165","article-title":"Synthesis and antibacterial activity of four natural chalcones and their derivatives","volume":"60","author":"Li","year":"2019","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmcl.2021.127827_b0230","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ejmech.2014.03.079","article-title":"Design, economical synthesis and antiplasmodial evaluation of vanillin derived allylated chalcones and their marked synergism with artemisinin against chloroquine resistant strains of Plasmodium falciparum","volume":"79","author":"Sharma","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2021.127827_b0235","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.carres.2010.10.017","article-title":"Application of click chemistry towards an efficient synthesis of 1, 2, 3\u20131H-triazolyl glycohybrids as enzyme inhibitors","volume":"346","author":"Anand","year":"2011","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.bmcl.2021.127827_b0240","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1016\/j.bmc.2006.01.003","article-title":"Anticancer activities of novel chalcone and bis-chalcone derivatives","volume":"14","author":"Modzelewska","year":"2006","journal-title":"Bioorg Med. Chem"},{"key":"10.1016\/j.bmcl.2021.127827_b0245","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0968-0896(00)00249-2","article-title":"Synthetic and biological activity evaluation studies on novel 1, 3-diarylpropenones","volume":"9","author":"Mukherjee","year":"2001","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2021.127827_b0250","article-title":"Trans-chalcone increases p53 activity via DNAJB1\/HSP40 induction and CRM1 inhibition","volume":"13","author":"Silva","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmcl.2021.127827_b0255","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejmech.2016.06.016","article-title":"Synthesis and biological evaluation of isomeric methoxy substitutions on anti-cancer indolyl-pyridinyl-propenones: Effects on potency and mode of activity","volume":"122","author":"Trabbic","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2021.127827_b0260","series-title":"Natural compounds in cancer therapy","author":"Boik","year":"2001"},{"key":"10.1016\/j.bmcl.2021.127827_b0265","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1021\/jm901757t","article-title":"Exploring the structural requirements for inhibition of the ubiquitin E3 ligase breast cancer associated protein 2 (BCA2) as a treatment for breast cancer","volume":"53","author":"Brahemi","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2021.127827_b0270","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/914813","article-title":"African flora has the potential to fight multidrug resistance of cancer","volume":"2015","author":"Kuete","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.bmcl.2021.127827_b0275","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.phymed.2017.07.010","article-title":"Cytotoxicity and mode of action of a naturally occurring naphthoquinone, 2-acetyl-7-methoxynaphtho[2,3-b]furan-4,9-quinone towards multi-factorial drug-resistant cancer cells","volume":"33","author":"Kuete","year":"2017","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bmcl.2021.127827_b0280","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fphar.2017.00343","article-title":"Potential of Central, Eastern and Western Africa medicinal plants for cancer therapy: spotlight on resistant cells and molecular targets","volume":"8","author":"Mbaveng","year":"2017","journal-title":"Front Pharmacol"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21000536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21000536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:38:15Z","timestamp":1760773095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X21000536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":56,"alternative-id":["S0960894X21000536"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.127827","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, characterization, and anticancer activity of a novel series of O-substituted chalcone derivatives","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.127827","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"127827"}}